PTC Therapeutics Inc/ US69366J2006 /
2024-04-25 4:22:12 PM | Chg. -0.6800 | Volume | Bid4:22:12 PM | Ask4:22:12 PM | High | Low |
---|---|---|---|---|---|---|
24.5300USD | -2.70% | 101,833 Turnover: 1.82 mill. |
24.4100Bid Size: 400 | 24.6100Ask Size: 400 | 24.8100 | 23.9950 |
GlobeNewswire
03-19
ClearPoint Neuro Congratulates its Partner PTC Therapeutics on Completion of Biologics License Appli...
GlobeNewswire
01-26
PTCT ALERT: Johnson Fistel Encourages Investors to Inquire About PTC Therapeutics Securities Class A...
GlobeNewswire
01-03
US Neurologists Optimistic Regarding the Huntington’s Disease Treatment Pipeline, Emphasizing Haltin...
GlobeNewswire
2023-11-07
Replimune Reports Fiscal Second Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
2023-10-19
Royalty Pharma Announces Agreement to Purchase Up to $1.5 Billion of PTC Therapeutics’ Royalty on Ev...
GlobeNewswire
2023-09-12
Sensorium Therapeutics Appoints Veteran Life Sciences Executive Mr. David Southwell to its Board of ...
GlobeNewswire
2023-08-28
Muscular Dystrophy Association Kicks Off 30 Days of Strength Campaign for National Muscular Dystroph...
GlobeNewswire
2021-11-08
Ring Therapeutics Strengthens Leadership Team with Three Executive Appointments
GlobeNewswire
2021-08-23
Adverum Appoints Global Regulatory Leader Jim Wang, Ph.D., as Senior Vice President, Head of Regulat...
GlobeNewswire
2021-04-15
Adverum Files Definitive Proxy Materials and Mails Letter to Stockholders Detailing Strength of Team...
GlobeNewswire
2021-03-17
Adverum Announces Board Slate for 2021 Annual Meeting and Reiterates Commitment to Stockholder Value...
GlobeNewswire
2021-03-02
Orchard Therapeutics Reports 2020 Financial Results and Reviews Recent Accomplishments
GlobeNewswire
2021-02-22
Aevitas Therapeutics Appoints Markus Peters, Ph.D., M.Sc., as Chief Executive Officer